Vetter Pharma International

www.vetter-pharma.com

Eywiesenstrasse 5
Ravensburg
D-88212
Germany

+49 751 37000

Activities

Summary

Vetter is a leading contract development and manufacturing organization (CDMO) that specialises in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with biologics and other complex compounds, including monoclonal antibodies, peptides, interferons and vaccines.

Profile

Collaborating with pharma/biotech clients worldwide, Vetter supports products from preclinical development through global market supply. Through its US and European facilities, Vetter Development Service provides state-of-the-art support for early-stage products, with seamless transfer at Phase III to Vetter Commercial Manufacturing for large-scale production. The company offers state-of-the-art technology and innovative processes to promote product quality and maximise API yield.

Vetter’s international success arises from its three interdependent divisions:

Vetter Development Service

At Vetter Development Service, we partner with our clients from preclinical development through Phase III. Because we plan for commercial production from a product’s earliest stages, we develop processes that mirror those at our commercial production facilities. That enables seamless product transfer at Phase III to Vetter Commercial Manufacturing for scale-up and large-scale production. With a growing need for early-stage support in North America, in 2011 we expanded Vetter Development Service to Chicago, Vetter’s first U.S. facility.

Vetter Development Service provides:

  • Formulation support
  • Process development
  • Clinical trial manufacturing
  • Analytical service
  • Regulatory support

Learn more about Vetter Development Service (PDF)

Vetter Commercial Manufacturing

Vetter Commercial Manufacturing provides Phase III clinical manufacturing through global market supply, featuring:

  • Fill and finish
  • Analytical service
  • Regulatory support
  • Product life cycle management

To strengthen security of supply, we take active steps both downstream and upstream to maintain the integrity of the supply chain, including regular quality reviews of all suppliers and cross-linked IT systems to monitor manufacturing processes. Vetter manufactures products for the top 10 pharma/biotech firms
worldwide.

Learn more about Vetter Commercial Manufacturing (PDF)

Vetter Packaging Solutions

Vetter Packaging Solutions helps clients match their product with the appropriate drug-delivery system (primary packaging); secondary packaging, such as cartoning or blister packing; and packaging services, such as pen-system assembly. Vetter Packaging Solutions provides:

  • Customised packaging development
  • Specialised technologies
  • Proven platform technologies
  • Packaging services
  • Logistic services

Learn more about Vetter Packaging Solutions (PDF)

Fast facts: Vetter-at-a-glance

  • Headquarters in Ravensburg, Germany
  • Additional clinical development facility in Chicago, US
  • Approximately 3,000 employees
  • Worldwide specialist in the aseptic production of prefilled drug delivery systems
  • Global experience and expertise with regulatory authorities, including FDA, EMA, PMDA (Japan), and RP (Germany), in multiple countries, including Canada, Russia, Brazil, Mexico and Saudi Arabia
  • Produced units 2012: 188 million
  • More than 25 customer products with FDA approval
  • Numerous patents including technologies for protection against tampering and counterfeiting
  • Lyophilisation (freeze-drying) and siliconisation specialist

Learn more about Vetter:

  • Corporate brochure - 'From clinical development to commercial production'
  • White Paper - 'Anticipating success: Meeting the inherent challenges of complex drug substances'